- Home
- GORO vs PDSB Comparison
GORO vs PDSB Comparison
Compare GORO & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORO
- PDSB
- Stock Information
- Founded
- GORO 1998
- PDSB 2005
- Country
- GORO United States
- PDSB United States
- Employees
- GORO N/A
- PDSB N/A
- Industry
- GORO Precious Metals
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- GORO Basic Materials
- PDSB Health Care
- Exchange
- GORO Nasdaq
- PDSB Nasdaq
- Market Cap
- GORO 53.3M
- PDSB 58.7M
- IPO Year
- GORO N/A
- PDSB N/A
- Fundamental
- Price
- GORO $0.51
- PDSB $1.19
- Analyst Decision
- GORO Strong Buy
- PDSB Strong Buy
- Analyst Count
- GORO 1
- PDSB 3
- Target Price
- GORO $1.25
- PDSB $10.00
- AVG Volume (30 Days)
- GORO 2.7M
- PDSB 807.1K
- Earning Date
- GORO 05-01-2025
- PDSB 03-27-2025
- Dividend Yield
- GORO N/A
- PDSB N/A
- EPS Growth
- GORO N/A
- PDSB N/A
- EPS
- GORO N/A
- PDSB N/A
- Revenue
- GORO $73,897,000.00
- PDSB N/A
- Revenue This Year
- GORO N/A
- PDSB $5,518.68
- Revenue Next Year
- GORO $48.90
- PDSB N/A
- P/E Ratio
- GORO N/A
- PDSB N/A
- Revenue Growth
- GORO N/A
- PDSB N/A
- 52 Week Low
- GORO $0.12
- PDSB $1.13
- 52 Week High
- GORO $0.74
- PDSB $4.42
- Technical
- Relative Strength Index (RSI)
- GORO 53.13
- PDSB 39.95
- Support Level
- GORO $0.45
- PDSB $1.19
- Resistance Level
- GORO $0.66
- PDSB $1.41
- Average True Range (ATR)
- GORO 0.07
- PDSB 0.10
- MACD
- GORO -0.00
- PDSB -0.00
- Stochastic Oscillator
- GORO 33.52
- PDSB 11.11
About GORO Gold Resource Corporation
Gold Resource Corp is a gold and silver producer, developer, and explorer with operations in Oaxaca, Mexico, and Nevada, USA. It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.